• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝脏疾病相关的严重低氧血症:梅奥诊所的经验及甲磺酸阿米三嗪的实验性应用

Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate.

作者信息

Krowka M J, Cortese D A

出版信息

Mayo Clin Proc. 1987 Mar;62(3):164-73. doi: 10.1016/s0025-6196(12)62438-0.

DOI:10.1016/s0025-6196(12)62438-0
PMID:3821178
Abstract

Severe hypoxemia associated with chronic liver disease is an uncommon disorder most likely due to an intrapulmonary vascular abnormality that has characteristics of both ventilation-perfusion mismatching and diffusion limitation. Anatomically, the intrapulmonary vascular abnormalities can occasionally be detected by angiography. Physiologically, the gas exchange abnormalities can be substantiated by contrast-enhanced two-dimensional echocardiography. Although orthodeoxia and platypnea have frequently been found in these patients, echocardiographic data suggest that vascular abnormalities can exist in the absence of orthodeoxia. We describe 11 patients who had severe hypoxemia and chronic liver disease and review their pulmonary angiographic, contrast echocardiographic, and arterial blood gas findings. Among five of these patients who were given almitrine bismesylate, an experimental medication thought to alter ventilation-perfusion relationships in patients with chronic obstructive pulmonary disease, one had improved oxygenation. We recommend that patients with hypoxemia associated with chronic liver disease have detailed studies to rule out reversible forms of hypoxemia and that those with severe hypoxemia undergo testing to determine the existence of intrapulmonary vascular abnormalities, especially if liver transplantation is considered.

摘要

与慢性肝病相关的严重低氧血症是一种罕见的病症,很可能是由于一种肺内血管异常所致,这种异常具有通气-灌注不匹配和弥散受限的特征。从解剖学角度来看,肺内血管异常偶尔可通过血管造影检测到。从生理学角度来看,气体交换异常可通过对比增强二维超声心动图得到证实。尽管在这些患者中经常发现直立性低氧血症和平卧呼吸,但超声心动图数据表明,在没有直立性低氧血症的情况下也可能存在血管异常。我们描述了11例患有严重低氧血症和慢性肝病的患者,并回顾了他们的肺血管造影、对比超声心动图和动脉血气检查结果。在这11例患者中,有5例接受了双嘧达莫,这是一种被认为可改变慢性阻塞性肺疾病患者通气-灌注关系的实验性药物,其中1例患者的氧合情况有所改善。我们建议,患有与慢性肝病相关的低氧血症的患者应进行详细检查,以排除可逆性低氧血症的形式,而那些患有严重低氧血症的患者应接受检查,以确定是否存在肺内血管异常,特别是在考虑进行肝移植的情况下。

相似文献

1
Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate.与肝脏疾病相关的严重低氧血症:梅奥诊所的经验及甲磺酸阿米三嗪的实验性应用
Mayo Clin Proc. 1987 Mar;62(3):164-73. doi: 10.1016/s0025-6196(12)62438-0.
2
The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.二甲磺酸阿米三嗪对慢性阻塞性肺疾病低氧血症的影响。
Ann Intern Med. 1986 Sep;105(3):342-6. doi: 10.7326/0003-4819-105-3-342.
3
Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.二甲磺酸阿米三嗪对慢性阻塞性肺疾病患者清醒和睡眠期间氧合的长期影响
Am J Med. 1988 Mar;84(3 Pt 1):436-44. doi: 10.1016/0002-9343(88)90263-x.
4
A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia.甲磺酸阿米三嗪与侧卧位对单侧细菌性肺炎伴严重低氧血症影响的比较研究
Am Rev Respir Dis. 1992 Aug;146(2):295-9. doi: 10.1164/ajrccm/146.2.295.
5
[Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
Respiration. 1985;48(4):285-95. doi: 10.1159/000194842.
6
Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
Eur J Respir Dis Suppl. 1983;126:255-64.
7
Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
Eur J Respir Dis Suppl. 1983;126:249-54.
8
Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.低剂量双甲磺酸阿米三嗪治疗慢性阻塞性肺疾病所致低氧血症
Chest. 1994 May;105(5):1383-91. doi: 10.1378/chest.105.5.1383.
9
Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial).双嘧达莫与慢性阻塞性肺疾病患者的低氧血症(一项意大利多中心试验的结果)
Eur J Respir Dis Suppl. 1986;146:677-83.
10
Does almitrine bismesylate improve V/Q matching? An animal study.
Eur J Respir Dis Suppl. 1983;126:209-14.

引用本文的文献

1
Bubble Trouble in COVID-19.新冠疫情中的气泡问题
Am J Respir Crit Care Med. 2020 Oct 1;202(7):926-928. doi: 10.1164/rccm.202008-3096ED.
2
Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.肝肺综合征与门肺高压:肝病的肺血管谜团
Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S13-S24. doi: 10.1002/cld.846. eCollection 2020 Feb.
3
Review article: Update on current and emergent data on hepatopulmonary syndrome.综述文章:有关肝肺综合征的当前和新兴数据的更新。
World J Gastroenterol. 2018 Mar 28;24(12):1285-1298. doi: 10.3748/wjg.v24.i12.1285.
4
Abnormal Gas Diffusing Capacity and Portosystemic Shunt in Patients With Chronic Liver Disease.慢性肝病患者的气体弥散能力异常与门体分流
Gastroenterology Res. 2012 Oct;5(5):182-189. doi: 10.4021/gr475e. Epub 2012 Sep 20.
5
Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors.接受肝叶切除术治疗肝肿瘤的犬长期存活相关因素。
Can Vet J. 2015 Jun;56(6):598-604.
6
Cirrhosis and hepatopulmonary syndrome.肝硬化与肝肺综合征。
World J Gastroenterol. 2014 Mar 14;20(10):2586-94. doi: 10.3748/wjg.v20.i10.2586.
7
The effects of flavanoid on the treatment of hepatopulmonary syndrome.类黄酮对肝肺综合征的治疗作用。
J Korean Surg Soc. 2013 Nov;85(5):219-24. doi: 10.4174/jkss.2013.85.5.219. Epub 2013 Oct 25.
8
The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.大蒜在肝肺综合征中的作用:一项随机对照试验。
Can J Gastroenterol. 2010 Mar;24(3):183-8. doi: 10.1155/2010/349076.
9
Current concepts in the management of hepatopulmonary syndrome.肝肺综合征管理的当前概念
Vasc Health Risk Manag. 2008;4(5):1035-41. doi: 10.2147/vhrm.s3608.
10
Impact of mild and moderate intrapulmonary shunting in children with end-stage liver disease undergoing liver transplantation.
World J Surg. 2007 Jul;31(7):1474-9. doi: 10.1007/s00268-007-9063-x. Epub 2007 May 16.